STOCK TITAN

EOM PHARMACEUTICAL HLDNGS (IMUC) Net Income by Year

IMUC

EOM PHARMACEUTICAL HLDNGS reported a net loss of $14.3M in fiscal year 2017. This represents an increase of 35.2% from the prior fiscal year. The table below carries 13 fiscal years, from 2005 to 2017, and the quarters EOM PHARMACEUTICAL HLDNGS has filed alongside them.

FY2017 annual
Net Income -$14.3M
YoY +35.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2018, ended Jun 30, 2018 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IMUC Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-KFY0910-KFY0810-KFY0710-KFY0610-KFY0510-K
Net Income-$14.3M+35.2%-$22.1M-72.7%-$12.8M-36.4%-$9.4M-6.6%-$8.8M+39.3%-$14.5M-153.4%-$5.7M+7.0%-$6.2M-134.2%-$2.6M+14.2%-$3.1M+15.4%-$3.6M+29.8%-$5.2M-1994.6%-$246K

IMUC Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'1810-QQ1'1810-QQ4'1710-QQ3'1710-QQ2'1710-QQ1'1710-QQ4'1610-KQ3'1610-QQ2'1610-QQ1'1610-QQ4'1510-KQ3'1510-Q
Net Income-$307K+92.4%-$1.0M+82.7%N/A-$3.9M+18.7%-$4.1M+24.0%-$5.9M-5.2%N/A-$4.8M-41.1%-$5.3M-68.9%-$5.6M-295.4%N/A-$3.4M-80.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More EOM PHARMACEUTICAL HLDNGS financials

Frequently Asked Questions

What was EOM PHARMACEUTICAL HLDNGS's net income in fiscal year 2017?

EOM PHARMACEUTICAL HLDNGS reported a net loss of $14.3M in fiscal year 2017.

How fast is EOM PHARMACEUTICAL HLDNGS's net income growing?

EOM PHARMACEUTICAL HLDNGS (IMUC) net income rose by 35.2% year over year, from -$22.1M to -$14.3M in fiscal year 2017.

How has EOM PHARMACEUTICAL HLDNGS's net income changed over the years?

Across the 13 fiscal years this page covers, EOM PHARMACEUTICAL HLDNGS (IMUC) net income went from -$246K in fiscal year 2005 to -$14.3M in fiscal year 2017.

EOM PHARMACEUTICAL HLDNGS (IMUC) reported -$307K in net income in Q2 2018. This represents an increase of 92.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what EOM PHARMACEUTICAL HLDNGS (IMUC) reported on that line in every period on record.